, Volume 62, Issue 1, pp 34–45 | Cite as

Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis

  • Ziqi Lin
  • Yue Wang
  • Bao Zhang
  • Zhen JinEmail author



Current studies have detected the correlation of polymorphisms in type 2 diabetes susceptible genes GCKR, SLC30A8 and FTO with gestational diabetes mellitus (GDM) risk. However, findings of these studies were incongruous. Hence, we performed an integrated review and meta-analysis for the researches regarding the association of single nucleotide polymorphisms (SNPs) in GCKR, SLC30A8 and FTO genes and GDM risk.


Eligible publications were selected on the basis of several inclusion and exclusion criteria. Correlation between each SNP and GDM risk was estimated by computing odds ratios (ORs) with 95% confidence intervals (95%CIs).


Consequently, 19 case-control studies (from 16 citations) including 3636 GDM cases and 7229 GDM-free controls were participated in a meta-analysis of seven prevalent SNPs (GCKR rs1260326 and rs780094; SLC30A8 rs13266634 and rs11558471; FTO rs8050136, rs1421085 and rs9939609). Our results demonstrated that the rs780094, rs13266634 and rs9939609 SNPs were significantly associated with GDM risk. In stratified analysis, correlations of rs780094 and rs13266634 SNPs could be observed in Asian and Caucasian subgroups. Moreover, association between rs9939609 SNP and GDM risk was detected in Caucasian subgroup.


The GCKR rs780094, SLC30A8 rs13266634 and FTO rs9939609 SNPs were demonstrated to be the potential biomarkers for GDM risk prediction.


GCKR SLC30A8 FTO Single nucleotide polymorphism Gestational diabetes mellitus Risk 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

12020_2018_1651_MOESM1_ESM.doc (211 kb)
Supplementary Information


  1. 1.
    J. Brown et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database Syst. Rev. 5, CD011970 (2017)PubMedGoogle Scholar
  2. 2.
    E.A. Reece, G. Leguizamon, A. Wiznitzer, Gestational diabetes: the need for a common ground. Lancet 373(9677), 1789–1797 (2009)CrossRefPubMedGoogle Scholar
  3. 3.
    E.A.R. Goedegebure et al. Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: a multicentre retrospective cohort study. BMC Pregnancy Childbirth 18(1), 152 (2018)CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res. Clin. Pract. 103(3), 341–363 (2014)Google Scholar
  5. 5.
    M. Hod et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int. J. Gynaecol. Obstet. 131, S173–S211 (2015)CrossRefPubMedGoogle Scholar
  6. 6.
    A. Ferrara, Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30, S141–S146 (2007)CrossRefPubMedGoogle Scholar
  7. 7.
    Y. Zhu, C. Zhang, Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr. Diab. Rep. 16(1), 7 (2016)CrossRefPubMedGoogle Scholar
  8. 8.
    L. Bellamy et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373(9677), 1773–1779 (2009)CrossRefPubMedGoogle Scholar
  9. 9.
    Y. Zhang et al. Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect. BJOG 125(7), 784–793 (2017)CrossRefGoogle Scholar
  10. 10.
    L. Chen, D.J. Magliano, P.Z. Zimmet The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat. Rev. Endocrinol. 8(4), 228–236 (2011)CrossRefPubMedGoogle Scholar
  11. 11.
    A.O. Martin et al. Frequency of diabetes mellitus in mothers of probands with gestational diabetes: possible maternal influence on the predisposition to gestational diabetes. Am. J. Obstet. Gynecol. 151(4), 471–475 (1985)CrossRefPubMedGoogle Scholar
  12. 12.
    L.J. Scott et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316(5829), 1341–1345 (2007)CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    S. Su et al. The association between leptin receptor gene polymorphisms and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 121, 49–58 (2016)CrossRefPubMedGoogle Scholar
  14. 14.
    C. Zhang et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum. Reprod. Update 19(4), 376–390 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    R. Saucedo et al. Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus. Diabetol. Metab. Syndr. 9, 32 (2017)CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    M. Tarnowski et al. GCK, GCKR, FADS1, DGKB/TMEM195 and CDKAL1 gene polymorphisms in women with gestational diabetes. Can. J. Diabetes 41(4), 372–379 (2017)CrossRefPubMedGoogle Scholar
  17. 17.
    X. Wang et al. Investigation of miRNA-binding site variants and risk of gestational diabetes mellitus in Chinese pregnant women. Acta Diabetol. 54(3), 309–316 (2017)CrossRefPubMedGoogle Scholar
  18. 18.
    O. Anderka et al. Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors. J. Biol. Chem. 283(46), 31333–31340 (2008)CrossRefPubMedGoogle Scholar
  19. 19.
    F. Chimienti et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J. Cell. Sci. 119(Pt 20), 4199–4206 (2006)CrossRefPubMedGoogle Scholar
  20. 20.
    M. Tamaki et al. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J. Clin. Invest. 123(10), 4513–4524 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    T. Abarin et al. The impact of breastfeeding on FTO-related BMI growth trajectories: an application to the Raine pregnancy cohort study. Int. J. Epidemiol. 41(6), 1650–1660 (2012)CrossRefPubMedGoogle Scholar
  22. 22.
    A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603–605 (2010)CrossRefPubMedGoogle Scholar
  23. 23.
    N. Mantel, W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22(4), 719–748 (1959)PubMedGoogle Scholar
  24. 24.
    R. DerSimonian, N. Laird, Meta-analysis in clinical trials. Control. Clin. Trials 7(3), 177–188 (1986)CrossRefPubMedGoogle Scholar
  25. 25.
    F.M. Matschinsky, B. Glaser, M.A. Magnuson, Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 47(3), 307–315 (1998)CrossRefPubMedGoogle Scholar
  26. 26.
    M. Orho-Melander et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57(11), 3112–3121 (2008)CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    M.G. Rees et al. Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes. J. Clin. Invest. 122(1), 205–217 (2012)CrossRefPubMedGoogle Scholar
  28. 28.
    M.I. Anghebem-Oliveira et al., The GCKR gene polymorphism rs780094 is a risk factor for gestational diabetes in a Brazilian population. J. Clin. Lab. Anal. 31(2) (2017)CrossRefGoogle Scholar
  29. 29.
    N.A. Seman et al. Increased DNA methylation of the SLC30A8 gene promoter is associated with type 2 diabetes in a Malay population. Clin. Epigenetics 7, 30 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    T. Sparso et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51(1), 70–75 (2008)CrossRefPubMedGoogle Scholar
  31. 31.
    A.M. Stuebe et al. Maternal genotype and gestational diabetes. Am. J. Perinatol. 31(1), 68–76 (2014)Google Scholar
  32. 32.
    F. Chimienti et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53(9), 2330–2337 (2004)CrossRefPubMedGoogle Scholar
  33. 33.
    Y. Fu et al. Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS. One. 4(5), e5679 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    M. Tamaki et al. Downregulation of ZnT8 expression in pancreatic beta-cells of diabetic mice. Islets 1(2), 124–128 (2009)CrossRefPubMedGoogle Scholar
  35. 35.
    J. Dereke et al. The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes. Endocrine 53(3), 740–746 (2016)CrossRefPubMedGoogle Scholar
  36. 36.
    S. Carvalho et al. Differential cytolocation and functional assays of the two major human SLC30A8 (ZnT8) isoforms. J. Trace Elem. Med. Biol. 44, 116–124 (2017)CrossRefPubMedGoogle Scholar
  37. 37.
    I. Kim et al. A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion. Pharm. J. 11(3), 191–198 (2011)Google Scholar
  38. 38.
    T.J. Nicolson et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58(9), 2070–2083 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    J. Lauenborg et al. Common type 2 diabetes risk gene variants associate with gestational diabetes. J. Clin. Endocrinol. Metab. 94(1), 145–150 (2009)CrossRefPubMedGoogle Scholar
  40. 40.
    A. Teleginski et al. Leptin (rs7799039) and solute carrier family 30 zinc transporter (rs13266634) polymorphisms in Euro-Brazilian pregnant women with gestational diabetes. Genet. Mol. Res. 16(1) (2017)Google Scholar
  41. 41.
    T.M. Frayling et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889–894 (2007)CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    R.J. Loos, C. Bouchard FTO: the first gene contributing to common forms of human obesity. Obes. Rev. 9(3), 246–250 (2008)CrossRefPubMedGoogle Scholar
  43. 43.
    M. Merkestein et al. FTO influences adipogenesis by regulating mitotic clonal expansion. Nat. Commun. 6, 6792 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    M. Franzago et al. Nutrigenetic variants and cardio-metabolic risk in women with or without gestational diabetes. Diabetes Res. Clin. Pract. 137, 64–71 (2018)CrossRefPubMedGoogle Scholar
  45. 45.
    Y. Yang et al. FTO genotype and type 2 diabetes mellitus: spatial analysis and meta-analysis of 62 case-control studies from different regions. Genes 8(2) (2017)CrossRefPubMedCentralGoogle Scholar
  46. 46.
    M. Rivera et al. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. Br. J. Psychiatry 211(2), 70–76 (2017)CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    S. Jamalpour et al. A case-control study and meta-analysis confirm glucokinase regulatory gene rs780094 is a risk factor for gestational diabetes mellitus. Gene 125(7):784-793 (2018)Google Scholar
  48. 48.
    P.V. Popova et al. Effect of gene-lifestyle interaction on gestational diabetes risk. Oncotarget 8(67), 112024–112035 (2017)CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    M. Franzago et al. Molecular analysis of a genetic variants panel related to nutrients and metabolism: association with susceptibility to gestational diabetes and cardiometabolic risk in affected women. J. Diabetes Res. 2017, 4612623 (2017)CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    M.I. Anghebem-Oliveira et al. Type 2 diabetes-associated genetic variants of FTO, LEPR, PPARg, and TCF7L2 in gestational diabetes in a Brazilian population. Arch. Endocrinol. Metab. 61(3), 238–248 (2017)CrossRefPubMedGoogle Scholar
  51. 51.
    S.F. de Melo et al. Polymorphisms in FTO and TCF7L2 genes of Euro-Brazilian women with gestational diabetes. Clin. Biochem. 48(16-17), 1064–1067 (2015)CrossRefPubMedGoogle Scholar
  52. 52.
    A. Pagan et al. A gene variant in the transcription factor 7-like 2 (TCF7L2) is associated with an increased risk of gestational diabetes mellitus. Int. J. Endocrinol. 180, 77–82 (2014)Google Scholar
  53. 53.
    M. He et al. Association of rs13266634 polymorphism in zinc transporter solute carrier family 30-member 8 gene with gestational diabetes mellitus. Chin. J. Diabetes Mellit. 5(1), 38–43 (2013)Google Scholar
  54. 54.
    Y.M. Cho et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52(2), 253–261 (2009)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyShengjing Hospital Affiliated to China Medical UniversityShenyangChina

Personalised recommendations